Advances and controversies in grading and staging of renal cell carcinoma.
about
Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcomeIntegrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United StatesA nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesotheliomaElevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma.Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.Correcting the Shrinkage Effects of Formalin Fixation and Tissue Processing for Renal Tumors: toward Standardization of Pathological Reporting of Tumor SizeHistopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.Loss of VHL promotes progerin expression, leading to impaired p14/ARF function and suppression of p53 activity.MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade.Small renal mass biopsy--how, what and when: report from an international consensus panel.Biomarkers in renal cancer.Percutaneous renal tumour biopsy.Gleason and Fuhrman no longer make the grade.Clear cell renal cell carcinoma: Validation of WHO/ISUP grading.Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.[The WHO/ISUP grading system for renal carcinoma].Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features.Reply: Gleason and Fuhrman no longer make the grade.Fuhrman grading is inappropriate for papillary renal cell carcinoma.Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.The ISUP system of staging, grading and classification of renal cell neoplasia.Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status.The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival.Accurate Risk Assessment of Patients with Pathologic T3aN0M0 Renal Cell Carcinoma
P2860
Q28486028-77388596-D517-437C-886E-E5E90F79CE84Q28487676-6DEAC8FA-6122-4322-A63B-A9BDD37A80FAQ33840661-1BF36870-BF45-4F0B-AE98-C81A300C2F86Q33954959-E647763D-AEAC-4544-BE6C-3AB7BEE38D0BQ35674811-1AD0D25C-D791-496F-927A-8C999B23264AQ35856855-5CEB9A7D-58E9-4D20-9CA2-CDEC9ECABE10Q37022318-40EACD69-ACB1-4236-A2D4-0E3B260A03B2Q37126195-254334B0-BA23-4FBF-B310-9DEF53044A55Q37426976-5C86B42F-1F6B-495E-9932-B9FF4D43C090Q37708077-FFE1897F-DB16-4C88-B956-CB2EE32D79D8Q38151964-F0C2B9BE-9008-4A6B-A125-DE3D19C9F7CDQ38184386-DE49DDEB-99FC-49A3-AFCE-E52FB16F5F80Q38231652-02DCD589-0902-4B00-813C-33FCD4BA5BFCQ38565256-6703512B-AC94-4CB5-97FB-7544C77BF07EQ38674090-2C6875B0-FB8C-4E07-AE9A-F9112496AB95Q39735817-3013DBA5-3236-4C96-983A-1029F4F28882Q40714570-31774A42-30E7-4704-9E06-4D561371F7C4Q44452054-D8D0DE2B-09C3-40D8-BFB0-14269ED74333Q47576374-889353FC-0E6A-4DBC-864D-3CACD0497FA7Q48096450-7A765639-B184-4472-9995-8DE581E180BDQ51465750-9191F4B2-6A5E-4327-8D30-442DF80AE733Q52658572-A858FFA1-0840-473B-AF4C-02FF461BA12AQ52951714-8B53ACFF-7501-4F06-A057-80B2E8796B08Q53097603-E40E669F-C9B5-4069-AF2C-BB2F4650DE69Q54240564-A0F1FBD3-F3F2-423A-907B-8D26F0F969E8Q54940590-999227E6-5DFA-4BDD-911B-7194E44A42ADQ58734464-55141A22-7939-47E7-8C5C-CE315232AAC9
P2860
Advances and controversies in grading and staging of renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances and controversies in grading and staging of renal cell carcinoma.
@en
Advances and controversies in grading and staging of renal cell carcinoma.
@nl
type
label
Advances and controversies in grading and staging of renal cell carcinoma.
@en
Advances and controversies in grading and staging of renal cell carcinoma.
@nl
prefLabel
Advances and controversies in grading and staging of renal cell carcinoma.
@en
Advances and controversies in grading and staging of renal cell carcinoma.
@nl
P2860
P1433
P1476
Advances and controversies in grading and staging of renal cell carcinoma.
@en
P2093
Brett Delahunt
P2860
P2888
P304
P356
10.1038/MODPATHOL.2008.183
P478
22 Suppl 2
P577
2009-06-01T00:00:00Z